Pitcairn CO Gilead Sciences, Inc. Transaction History

Pitcairn CO

$1.67 Billion
Q3 2024

A detailed history of Pitcairn CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pitcairn CO holds 6,580 shares of GILD stock, worth $593,450. This represents 0.03% of its overall portfolio holdings.

Number of Shares

6,580

Previous 8,180 19.56%

Holding current value

$593,450

Previous $561,000 1.78%

% of portfolio

0.03%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$66.59 - $83.99 $106,544 - $134,384	-1,600 Reduced 19.56%	6,580 $551,000
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $34,732 - $40,084	550 Added 7.21%	8,180 $561,000
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $463,480 - $565,202	-6,475 Reduced 45.91%	7,630 $558,000
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $120,236 - $136,350	-1,641 Reduced 10.42%	14,105 $1.14 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $34,529 - $37,672	-467 Reduced 2.88%	15,746 $1.18 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $165,321 - $188,572	-2,175 Reduced 11.83%	16,213 $1.25 Million
Q1 2023 May 05, 2023	BUY	$77.31 - $88.08 $915,118 - $1.04 Million	11,837 Added 180.69%	18,388 $1.53 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $62,693 - $90,006	1,006 Added 18.14%	6,551 $562,000
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $11,669 - $13,329	-196 Reduced 3.41%	5,545 $342,000
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $2,481 - $2,795	43 Added 0.75%	5,741 $355,000
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $73,210 - $91,741	-1,264 Reduced 18.16%	5,698 $339,000
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $4,346 - $4,933	67 Added 0.97%	6,962 $506,000
Q3 2021 Nov 10, 2021	SELL	$67.69 - $73.03 $25,045 - $27,021	-370 Reduced 5.09%	6,895 $482,000
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $46,333 - $50,625	-730 Reduced 9.13%	7,265 $500,000
Q1 2021 May 10, 2021	BUY	$60.0 - $68.46 $720 - $821	12 Added 0.15%	7,995 $517,000
Q4 2020 Feb 05, 2021	SELL	$56.65 - $64.55 $26,398 - $30,080	-466 Reduced 5.52%	7,983 $465,000
Q3 2020 Nov 03, 2020	SELL	$62.1 - $78.08 $128,236 - $161,235	-2,065 Reduced 19.64%	8,449 $534,000
Q2 2020 Jul 28, 2020	BUY	$72.34 - $84.0 $44,995 - $52,248	622 Added 6.29%	10,514 $809,000
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $70,771 - $90,648	1,130 Added 12.9%	9,892 $740,000
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $55,704 - $61,273	-904 Reduced 9.35%	8,762 $569,000
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $98,390 - $108,606	-1,574 Reduced 14.0%	9,666 $612,000
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $128,875 - $144,518	2,083 Added 22.75%	11,240 $759,000
Q1 2019 May 07, 2019	SELL	$62.53 - $70.05 $374,429 - $419,459	-5,988 Reduced 39.54%	9,157 $595,000
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $816,381 - $1.07 Million	-13,485 Reduced 47.1%	15,145 $947,000
Q3 2018 Nov 02, 2018	SELL	$71.28 - $78.92 $351,054 - $388,681	-4,925 Reduced 14.68%	28,630 $2.21 Million
Q2 2018 Aug 02, 2018	SELL	$64.88 - $75.68 $34,256 - $39,959	-528 Reduced 1.55%	33,555 $2.38 Million
Q1 2018 May 11, 2018	BUY	$72.84 - $88.8 $121,060 - $147,585	1,662 Added 5.13%	34,083 $2.57 Million
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $99,396 - $116,677	-1,397 Reduced 4.13%	32,421 $2.32 Million
Q3 2017 Nov 03, 2017	BUY	$72.11 - $85.47 $2.44 Million - $2.89 Million	33,818	33,818 $2.74 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.

Account